|
|
 |
|
Viewing report
|
|
 |
 |
DNA Sequencing and PCR Markets
TriMark Publications, July 2008, Pages: 185
The focus of this report is to describe the specific segment of the life sciences market called DNA sequencing. This analysis includes all of the generally-accepted DNA-oriented analytical activities that are currently used today, such as enabling technologies like polymerase chain reaction (PCR). It examines these measurement technology platforms and their reagents and supplies as utilized in biotechnology research, pharmacology and healthcare. Generally, diagnostic tests which are marketed primarily as over-the-counter products directly to patients are not included in this study, although there is inevitably some overlap.
This examination will:
1) identify viable technology drivers through a comprehensive look at various platform technologies for molecular sequencing, including immunoassays electrophoretic methods, probe-based nucleic acid assays, microarrays and non-PCR sequencing
2) obtain a complete understanding of the chief molecular sequencing tests for predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic applications
3) discover feasible market opportunities via an identification of high-growth applications in different therapeutic areas, with a focus on the biggest and expanding markets–communicable diseases, cardiology and oncology
4) and focus on global industry development through an in-depth analysis of the major world markets for molecular sequencing, including forecasts for growth.
Product samples
DNA Sequencing and PCR Markets Sample
Customers who bought this item also bought
Global Market for DNA Sequencing Analysis, 2000-2008
Reagents and Equipment Sales for Use in DNA Sequencing Worldwide, 2002-2010
DNA/RNA Therapies: Translating The Genome Into A $1.2bn Market By 2010
The Worldwide Market for Protein Sequencing Instrumentation, 2002-2010
Lower Detection Limits of HBV DNA Assays
Molecular Diagnostics - Technologies, Markets and Companies
Molecular Diagnostics - Revolution or Hype
Molecular Diagnostics Markets
|
 |
|
|